• The Goldman Sachs Group Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $32.00

    Source: Buzz FX / 03 Mar 2025 10:16:16   America/New_York


    The Goldman Sachs Group Cuts Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $32.00 Written by MarketBeat March 3, 2025 Share Link copied to clipboard. Apellis Pharmaceuticals ( NASDAQ:APLS - Get Free Report ) had its target price low
    Read more...
Share on,